Evogene (EVGN) Set to Announce Quarterly Earnings on Thursday

Evogene (NASDAQ:EVGN) is scheduled to announce its earnings results before the market opens on Thursday, November 21st. Persons that wish to listen to the company’s earnings conference call can do so using this link.

Evogene (NASDAQ:EVGN) last released its earnings results on Thursday, August 22nd. The biotechnology company reported ($1.06) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.12) by ($0.94). The company had revenue of $0.91 million during the quarter. Evogene had a negative return on equity of 72.33% and a negative net margin of 210.26%.

Evogene Stock Down 2.9 %

NASDAQ:EVGN opened at $1.68 on Tuesday. The company has a market cap of $9.02 million, a P/E ratio of -0.44 and a beta of 1.43. The firm’s 50 day moving average is $2.49 and its two-hundred day moving average is $4.59. Evogene has a fifty-two week low of $1.66 and a fifty-two week high of $10.40.

Analyst Upgrades and Downgrades

A number of research analysts recently weighed in on the company. Lake Street Capital reduced their target price on Evogene from $30.00 to $12.00 and set a “buy” rating on the stock in a report on Friday, August 23rd. StockNews.com began coverage on Evogene in a research note on Monday. They issued a “sell” rating on the stock.

About Evogene

Evogene Ltd., together with its subsidiaries, operates as a computational biology company. It focuses on product discovery and development in life-science based industries, including human health and agriculture, through the use of its Computational Predictive Biology (CPB) platform. The company operates through three segments: Agriculture, Human Health, and Industrial Applications.